As pharmaceutical companies branch out to products and supplements with omega-3 fatty acids, it is likely to increase competition while expanding an already-robust market, industry observers say. "The involvement and early success of pharmaceutical companies in this space helps further legitimize omega-3s in the eyes of consumers and medical professionals," said Becky Wright of Aker BioMarine. "Omega-3 companies should welcome these players because it only elevates this game and prompts innovation."

Related Summaries